Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mutimer

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Gut|July 16, 2002
Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis CM Wali, R F Harrison, P J Gow, et al.
Gut|May 1, 1995
Fulminant hepatic failure caused by tuberculosisW Hussain, D Mutimer, R Harrison, et al.
Lancet (London, England)|May 13, 1995
Fluconazole prophylaxis for high-risk liver transplant recipientsN Kung, N Fisher, B Gunson, et al.
Transplantation|May 27, 1997
Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipientsD Mutimer, D Mirza, J Shaw, et al.
Quality in Health Care : QHC|February 7, 1994
Effects of a computerised protocol management system on ordering of clinical testsP G Nightingale, M Peters, D Mutimer, et al.
Rheumatology (Oxford, England)|September 19, 2001
Successful treatment of hepatitis B-associated vasculitis using lamivudine as the sole therapeutic agentA Filer, A Hughes, K Kane, et al.
European Journal of Gastroenterology & Hepatology|May 2, 2002
Hepatitis associated with Chinese herbsC A McRae, K Agarwal, D Mutimer, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 5, 2006
Low-dose amphotericin for prevention of serious fungal infection following liver transplantationT Shah, W K Lai, P Gow, et al.
Lancet (London, England)|May 28, 1994
Recovery despite impaired cerebral perfusion in fulminant hepatic failureM H Davies, D Mutimer, J Lowes, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Use of real-time PCR and fluorimetry to detect lamivudine resistance-associated mutations in hepatitis B virusP A Cane, P Cook, D Ratcliffe, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Gut|July 16, 2002
Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis CM Wali, R F Harrison, P J Gow, et al.
Gut|May 1, 1995
Fulminant hepatic failure caused by tuberculosisW Hussain, D Mutimer, R Harrison, et al.
Lancet (London, England)|May 13, 1995
Fluconazole prophylaxis for high-risk liver transplant recipientsN Kung, N Fisher, B Gunson, et al.
Transplantation|May 27, 1997
Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipientsD Mutimer, D Mirza, J Shaw, et al.
Quality in Health Care : QHC|February 7, 1994
Effects of a computerised protocol management system on ordering of clinical testsP G Nightingale, M Peters, D Mutimer, et al.
Rheumatology (Oxford, England)|September 19, 2001
Successful treatment of hepatitis B-associated vasculitis using lamivudine as the sole therapeutic agentA Filer, A Hughes, K Kane, et al.
European Journal of Gastroenterology & Hepatology|May 2, 2002
Hepatitis associated with Chinese herbsC A McRae, K Agarwal, D Mutimer, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 5, 2006
Low-dose amphotericin for prevention of serious fungal infection following liver transplantationT Shah, W K Lai, P Gow, et al.
Lancet (London, England)|May 28, 1994
Recovery despite impaired cerebral perfusion in fulminant hepatic failureM H Davies, D Mutimer, J Lowes, et al.
Antimicrobial Agents and Chemotherapy|July 2, 1999
Use of real-time PCR and fluorimetry to detect lamivudine resistance-associated mutations in hepatitis B virusP A Cane, P Cook, D Ratcliffe, et al.
Pageof 10